Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate Plus Rosuvastatin in Early Endometrial Carcinoma
NCT04491643Phase 2Completed
- Sponsor
- Fudan University
- Start
- Sep 2020
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in endometrial carcinoma, sponsored by Fudan University. Started Sep 2020; status: completed.
02
Drugs
rosuvastatin
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT04491643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04491643.